Leo Schaerer
Impact in
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research
- Oncology top 10%
- Cancer Cells and Metastasis
- Cutaneous Melanoma Detection and Management
Papers in
-
- Cutaneous lymphoproliferative disorders research 3
- Cancer and Skin Lesions 1
- Co-authors
- Reinhard Dummer (3 shared papers)Udo Döbbeling (1 shared paper)Ossia M. Eichhoff (1 shared paper)Natalie C. Schlegel (1 shared paper)Nikita Kobert (1 shared paper)Keith S. Hoek (1 shared paper)Silvio Hemmi (1 shared paper)Werner Kempf (3 shared papers)
- Journals
- Journal of Cutaneous Pathology (2 papers)American Journal of Dermatopathology (2 papers)The American Journal of Surgical Pathology (1 paper)Cancer Research (1 paper)
- Partner nations
- SwitzerlandGermanyAustria
In The Last Decade
Leo Schaerer
6 papers receiving 639 citations
Leo Schaerer's Hit Papers
Peers
Comparison fields: 5 of 59
- Dermatology 86
- Oncology 243
- Immunology and Allergy 50
- Cell Biology 144
- Immunology 142
Countries citing papers authored by Leo Schaerer
This map shows the geographic impact of Leo Schaerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Schaerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Schaerer more than expected).
Fields of papers citing papers by Leo Schaerer
This network shows the impact of papers produced by Leo Schaerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Schaerer. The network helps show where Leo Schaerer may publish in the future.
Co-authors
The 20 scholars most cited alongside Leo Schaerer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States Hit paper breakdown → | 2008 | 532 |
| 2 | 2012 | 57 | |
| 3 | 2000 | 27 | |
| 4 | 2006 | 15 | |
| 5 | 2001 | 8 | |
| 6 | 2013 | 6 |
About Leo Schaerer
Leo Schaerer is a scholar working on Dermatology, Pathology and Forensic Medicine, Oncology, Molecular Biology and Epidemiology, having authored 6 papers that have together received 645 indexed citations. Recurring topics across this work include Cutaneous lymphoproliferative disorders research (3 papers), Vascular Tumors and Angiosarcomas (1 paper), Cancer and Skin Lesions (1 paper), Genetic and rare skin diseases. (1 paper), Cancer Cells and Metastasis (1 paper), Immunotherapy and Immune Responses (1 paper), Cutaneous Melanoma Detection and Management (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Dermatology (86 citations), Oncology (243 citations), Immunology and Allergy (50 citations), Cell Biology (144 citations) and Immunology (142 citations). Leo Schaerer has collaborated with scholars based in Switzerland, Germany and Austria. Frequent co-authors include Reinhard Dummer, Udo Döbbeling, Ossia M. Eichhoff, Natalie C. Schlegel, Nikita Kobert, Keith S. Hoek, Silvio Hemmi, Werner Kempf, Heinz Kutzner and Sylvie Fraitag. Their work appears in journals such as Journal of Cutaneous Pathology, American Journal of Dermatopathology, The American Journal of Surgical Pathology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.